Aarkstore Enterprise Grupo Uriach - Product Pipeline Review - Q4 2010

Aarkstore announce a new report "Grupo Uriach - Product Pipeline Review - Q4 2010" through its vast collection of market research report.

Grupo Uriach - Product Pipeline Review - Q4 2010 provides data on the companys research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Directs team.

Scope

- Grupo Uriach - Brief company overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Grupo Uriach human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Grupo Uriach with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Grupo Uriachs pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Grupo Uriachs strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Grupo Uriach in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Grupo Uriachs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Grupo Uriach.

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Grupo Uriach and identify potential opportunities in those areas.

For more information, please visit:

http://www.aarkstore.com/reports/Grupo-Uriach-Product-Pipeline-Review-Q4-2010-86419.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

The Trend For Ugg Men The Pros and Cons to the U.S. Arms Production: Above which sold war for nearly nothing! Aarkstore Enterprise Imquest Life Sciences - Product Pipeline Review - Q4 2010 There Are Moncler Items On Sale Pink Shepherd Check Ruffles Sweet Lolita Dress, Classic Lolita Dress Very Important Yellow Box Shoes facts you should Know Intas Pharmaceuticals Ltd. - Product Pipeline Review - Q4 2010 Career In Fashion Communications For Collectors, Ballerina and Fashion Dolls Make Perfect Gifts Aarkstore Enterprise Ligocyte Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010 Aarkstore Enterprise Marina Biotech, Inc. - Product Pipeline Review - Q4 2010 A Natural Way Of Walking Shoes Provided By Mbt Viparo.com.au- Leather Garments Leather Bomber Jackets Biker Jackets Hooded Leather Jackets